Clinical research by Zepbound's manufacturer Eli Lilley found that the drug's active ingredient tirzepatide reduces sleep apnea by about 60%.
The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.
Lisa Jarvis In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their body weight, on average, a result that caused the Danish ...
NBA Hall of Famer Isiah Thomas announced Thursday that he has been diagnosed with Bell’s palsy. “I’ve gotten a lot of love ...
Only two people survived the crash, which happened as the plane was landing at an airport in the southwest. Officials said they were investigating the cause. The site of the crash in the evening ...
The president-elect made the announcement on Truth Social on Sunday. ABC News’ MaryAlice Parks discusses President Joe Biden's invitation for President-elect Donald Trump to visit the White ...
A passenger plane with 181 people on board erupted in flames after veering off the runway and crashing into a wall at an airport in Muan, South Korea, on Sunday, with authorities indicating that all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback